Four new non-executive directors join Indivior board
Juliet Thompson, Joanna Le Couilliard, Mark Stejbach and Jerome Lande have taken board roles at the pharmaceutical firm.
Image: Paulista/Shutterstock
Pharmaceutical company Indivior has appointed four new non-executive directors to its board.
Juliet Thompson, Joanna Le Couilliard and Mark Stejbach join as independent NEDs, with Jerome Lande, a partner at Indivior shareholder Scopia, joining as a NED.
Thompson is a former investment banker who has spent her career advising pharmaceutical companies. She currently chairs the audit committees of Novacyt and Vectura, and is also a non-executive director of Organox. She will be a member of the audit and nomination and governance committees, and will be appointed to chair the audit committee following the 2021 AGM in May.
Le Couilliard w
For thoughtful journalism, expert insights on corporate governance and an extensive library of reports, guides and tools to help boards and directors navigate the complexities of their roles, subscribe to Board Agenda
Related Stories
-
Stella David joins Domino’s Pizza as independent non-executive director
David is a former chief executive of drinks company William Grant & Sons and was global chief marketing officer at Bacardi.
-
De La Rue appoints Bray
IT specialist joins banknote maker to lead audit committee.
-
Investor ire sees Sir Mick Davis’s Rio Tinto chairmanship plan shelved
Rio Tinto backtracks on plan to appoint Sir Mick Davis as chairman, after an influential group representing a large tranche of shareholders expresses concern.
